Social Media Ideas for Clinical Trials

HHS launches initiatives to make clinical trials faster

HHS launched a multi-component effort intended to improve the speed and efficiency with which clinical trials are conducted.The series of initiatives is designed to eliminate dupli...

<![CDATA[EMA Steps Up Push for Greater Clinical Trial Transparency]]>

The Trials Were Always There — Patients Just Couldn’t Find Them

This structural problem calls for a structural solution, requiring no new science, regulation, or data.  The post The Trials Were Always There — Patients Just Couldn’t Find Them ap...

Innovative Trials launches global education programme as survey exposes major misconceptions about clinical trials

New research finds almost three quarters of UK adults believe they understand clinical trials, yet many misunderstand how they work. Now, Innovative Trials - a leading clinical tri...

<![CDATA[Accelerating patient recruitment: Connecting the right patients to the right trial]]>

<![CDATA[6 Ways Lab Data Can Improve Clinical Trials]]>

<![CDATA[Laboratory Advantage: End-to-End Solutions for Increased Complexity in Clinical Trials]]>

Clinical trial navigation is a clinical access problem

Clinical trial enrollment in rare cancers remains stubbornly low. In T-cell lymphomas, a heterogeneous group of over a dozen distinct subtypes affecting roughly 9,000 new patients...

<![CDATA[How AI is Being Used to Prevent Clinical Trial Mismatches]]>

<![CDATA[5 Essential Capabilities for Decentralized Clinical Trials]]>

HHS kicks off new programs to speed clinical trials as Chinese competition looms

The department is offering funding to teams with innovative proposals as it considers ending the traditional phased clinical trial system.

<![CDATA[BioNTech Terminates Phase II Clinical Trial for Cevumeran ]]>

<![CDATA[Is Your Clinical Trial Enrolling the Right Patients? Q&A with Jen Lamppa]]>

<![CDATA[RWD's Impact on Clinical Trial Recruitment Costs]]>

<![CDATA[Moving Beyond the Sample Size Guess: Lessons from 60 Million Clinical Trial Simulations]]>

<![CDATA[Revitalizing recruitment in a lupus rescue study: A collaborative approach by Quest Diagnostics and Patients...

Clinical Trials Begin in U.S. for First Cannabis-Based Medicine for Chronic Pain 

By Pat AnsonThe first clinical trials in the United States for a cannabis-based medicine for chronic pain are getting underway.New York State has authorized a clinical trial of VER...

Large Language Model–Assisted Review of Clinical Trial Informed Consent for Data Reuse: Retrieval-Augmented Generation A...

Background: Regulatory frameworks such as the Belmont Report, the Common Rule, and the Declaration of Helsinki require informed consent to ensure participants understand a study’s...

TA SHORTS: 9/16/2026

Participants needed for study Neighborhood Healthcare seeks participants for a drug study related to heart disease and stroke.  The community health organization’s Institute of Hea...

FDA launches pilot program to speed up early US drug research

First teased in June and formally announced Tuesday as part of “Operation Trialblazer,” the program will partner drugmakers with research institutions to more quickly bring medicin...

SIMEDHealth Joins the Innovo Research Network, Bringing Community-Based Clinical Trials to More Patients Across North Ce...

Gainesville-based multispecialty group adds six campuses, 90+ providers and 150+ completed trials to Innovo's national network of embedded community research sites GAINESVILLE, Fla...

New therapy moves closer to Phase 2 testing in progressive MS

Quantum Biopharma is collaborating with Thermo Fisher Scientific to prepare a Phase 2 clinical trial of Lucid-MS, an experimental oral therapy designed to slow myelin loss, in peop...

Clinical trials for Alzheimer’s treatment face global shortage of participants

The shortage of trial participants risks slowing progress in dementia therapies, Alzheimer's Disease International warns.

First Patient Dosed in Phase III Perioperative Study of Cadonilimab (PD-1/CTLA-4) in Colon Cancer

HONG KONG, Oct. 10, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase III clinical study (COMPASSION-...